Variant report
Variant | nsv1033431 |
---|---|
Chromosome Location | chr9:1378131-1403641 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533358194 | chr9:1378131-1378132 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576314368 | chr9:1378180-1378181 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369277546 | chr9:1378185-1378186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550302478 | chr9:1378224-1378225 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1412250 | chr9:1378243-1378244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565121630 | chr9:1378281-1378282 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527485402 | chr9:1378284-1378285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541184448 | chr9:1378285-1378286 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561382887 | chr9:1378287-1378288 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs34858716 | chr9:1378302-1378303 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530187516 | chr9:1378313-1378314 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550174936 | chr9:1378314-1378315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138407454 | chr9:1378333-1378334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531269672 | chr9:1378345-1378346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532878513 | chr9:1378368-1378369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552594819 | chr9:1378398-1378399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs373742139 | chr9:1378411-1378412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143090714 | chr9:1378417-1378418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535642171 | chr9:1378420-1378421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187628073 | chr9:1378425-1378426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567044917 | chr9:1378431-1378432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145153825 | chr9:1378459-1378460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115055748 | chr9:1378461-1378462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs138925704 | chr9:1378468-1378469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149355972 | chr9:1378499-1378500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs533574115 | chr9:1378515-1378516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572334453 | chr9:1378516-1378517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs13290677 | chr9:1378523-1378524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541249393 | chr9:1378541-1378542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs13295667 | chr9:1378551-1378552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112604168 | chr9:1378573-1378574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs538948791 | chr9:1378583-1378584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192596228 | chr9:1378602-1378603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144657228 | chr9:1378611-1378612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77988084 | chr9:1378641-1378642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539357980 | chr9:1378647-1378648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532408602 | chr9:1378665-1378666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115765483 | chr9:1378706-1378707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs665130 | chr9:1378707-1378708 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs528733572 | chr9:1378736-1378737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530829010 | chr9:1378764-1378765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12346472 | chr9:1378772-1378773 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs536387827 | chr9:1378795-1378796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs549612822 | chr9:1378803-1378804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148544875 | chr9:1378829-1378830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538271835 | chr9:1378831-1378832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs143912279 | chr9:1378846-1378847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572395248 | chr9:1378867-1378868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12341801 | chr9:1378881-1378882 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs558157366 | chr9:1378914-1378915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:1373600-1384000 | Weak transcription | Adipose Nuclei | Adipose |
2 | chr9:1377200-1378200 | Enhancers | Fetal Muscle Leg | muscle |
3 | chr9:1378000-1378400 | Enhancers | Psoas Muscle | Psoas |
4 | chr9:1378200-1384000 | Weak transcription | Fetal Muscle Leg | muscle |
5 | chr9:1379600-1384800 | Weak transcription | Psoas Muscle | Psoas |
6 | chr9:1383600-1385400 | Enhancers | Fetal Lung | lung |
7 | chr9:1384000-1384200 | Enhancers | Fetal Muscle Leg | muscle |
8 | chr9:1384000-1386200 | Enhancers | Adipose Nuclei | Adipose |
9 | chr9:1384200-1385000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr9:1384200-1386400 | Weak transcription | Fetal Muscle Leg | muscle |
11 | chr9:1384800-1385000 | Enhancers | Psoas Muscle | Psoas |
12 | chr9:1386200-1387800 | Weak transcription | Adipose Nuclei | Adipose |
13 | chr9:1386400-1386800 | Enhancers | Fetal Muscle Leg | muscle |
14 | chr9:1387800-1388000 | Enhancers | Adipose Nuclei | Adipose |
15 | chr9:1401600-1401800 | Enhancers | Brain Inferior Temporal Lobe | brain |
16 | chr9:1401600-1402400 | Enhancers | Brain Cingulate Gyrus | brain |
17 | chr9:1401600-1402400 | Enhancers | Brain Substantia Nigra | brain |
18 | chr9:1401800-1402800 | Weak transcription | Brain Inferior Temporal Lobe | brain |
19 | chr9:1402000-1402400 | Enhancers | Brain Hippocampus Middle | brain |
20 | chr9:1402400-1402800 | Weak transcription | Brain Hippocampus Middle | brain |
21 | chr9:1402400-1403200 | Weak transcription | Brain Cingulate Gyrus | brain |
22 | chr9:1402400-1403400 | Weak transcription | Brain Substantia Nigra | brain |
23 | chr9:1402800-1403400 | Enhancers | Brain Hippocampus Middle | brain |
24 | chr9:1402800-1403600 | Enhancers | Brain Inferior Temporal Lobe | brain |
25 | chr9:1403000-1403400 | Enhancers | Brain Angular Gyrus | brain |
26 | chr9:1403200-1403400 | Enhancers | Brain Cingulate Gyrus | brain |
27 | chr9:1403400-1403600 | Enhancers | Brain Substantia Nigra | brain |